| Dr Todd Webster Pacofsky, DMD | |
|
2446 Fenton St, Suite 102, Chula Vista, CA 91914-3516 | |
| (619) 216-1100 | |
| (619) 216-1127 |
| Full Name | Dr Todd Webster Pacofsky |
|---|---|
| Gender | Male |
| Speciality | Dentist - Pediatric Dentistry |
| Location | 2446 Fenton St, Chula Vista, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699815852 | NPI | - | NPPES |
| D50503 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0221X | Dentist - Pediatric Dentistry | 50503 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Todd Webster Pacofsky, DMD 2446 Fenton St, Suite 102, Chula Vista, CA 91914-3516 Ph: (619) 216-1100 | Dr Todd Webster Pacofsky, DMD 2446 Fenton St, Suite 102, Chula Vista, CA 91914-3516 Ph: (619) 216-1100 |
News Archive
While the pipeline of new antibiotics has improved over the past six years, momentum in the development of new infection-fighting agents remains inadequate and could take a significant downturn without new incentives, a report released in Clinical Infectious Diseases shows.
Researchers in the Division of Cancer Prevention, Department of Medicine, at Stony Brook University have discovered that a novel derivative of sulindac, a non-steroidal anti-inflammatory drug (NSAID) known to prevent colon cancer, is more effective and safer than sulindac in preventing colon cancer in animals. The study results are reported in the October issue of the journal Gastroenterology.
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have identified a potential new avenue for altering lung development in the embryo which may help to improve the outcome for very premature babies.
Neuren Pharmaceuticals has announced that Mr Larry Glass, Executive Vice President and head of Neuren's US operations, has been invited by the US Army to present Neuren's clinical trial strategy for NNZ-2566 at the Advanced Technology Applications for Combat Casualty Care (ATACCC) conference.
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the first quarter of fiscal year ended July 31, 2016.
› Verified 8 days ago
Dr. Federico G Drachenberg, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 890 Eastlake Parkway, Ste 101, Chula Vista, CA 91914 Phone: 619-934-3258 Fax: 619-651-7578 | |
Evelyn Lugue Salazar, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1101 Broadway, Chula Vista, CA 91911 Phone: 619-422-8891 Fax: 619-422-4356 | |
Dr. Graciela L Lopez, DDS Dentist Medicare: Medicare Enrolled Practice Location: 301 3rd Ave, Chula Vista, CA 91910 Phone: 619-476-1444 Fax: 619-476-0656 | |
Luis E Real, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 690 E St, Chula Vista, CA 91910 Phone: 619-425-2122 Fax: 619-425-2125 | |
Karen Yong Liu, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 885 Canarios Court, Suite 202, Chula Vista, CA 91910 Phone: 619-656-6800 Fax: 619-656-0200 | |
Dr. Mercedes F Razo, D.D.S,M.A.G.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 885 Canarios Ct, #210, Chula Vista, CA 91910 Phone: 619-656-4199 Fax: 619-656-6945 | |
Ruth Garcia Rosas, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2452 Fenton St Ste 200, Chula Vista, CA 91914 Phone: 619-934-6620 |